nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Alkylating Activity—Estramustine—prostate cancer	0.897	1	CiPCiCtD
Altretamine—Affective disorder—Mitoxantrone—prostate cancer	0.00363	0.0353	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Cabazitaxel—prostate cancer	0.00361	0.0351	CcSEcCtD
Altretamine—Ovarian cancer—Conjugated Estrogens—prostate cancer	0.00352	0.0342	CcSEcCtD
Altretamine—Myelosuppression—Estramustine—prostate cancer	0.00295	0.0287	CcSEcCtD
Altretamine—Ovarian cancer—Estradiol—prostate cancer	0.00282	0.0274	CcSEcCtD
Altretamine—Ovarian cancer—Docetaxel—prostate cancer	0.00181	0.0176	CcSEcCtD
Altretamine—Neoplasm malignant—Flutamide—prostate cancer	0.00143	0.0139	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Abiraterone—prostate cancer	0.00134	0.0131	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Nilutamide—prostate cancer	0.00123	0.0119	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Abiraterone—prostate cancer	0.00112	0.0109	CcSEcCtD
Altretamine—Neoplasm—Flutamide—prostate cancer	0.0011	0.0107	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Degarelix—prostate cancer	0.0011	0.0107	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Capecitabine—prostate cancer	0.00107	0.0104	CcSEcCtD
Altretamine—Neoplasm malignant—Bicalutamide—prostate cancer	0.00104	0.0101	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Nilutamide—prostate cancer	0.00102	0.00995	CcSEcCtD
Altretamine—Neurotoxicity—Etoposide—prostate cancer	0.000976	0.00949	CcSEcCtD
Altretamine—Myelosuppression—Mitoxantrone—prostate cancer	0.00097	0.00944	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Degarelix—prostate cancer	0.000914	0.00889	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Bicalutamide—prostate cancer	0.000886	0.00861	CcSEcCtD
Altretamine—Pancytopenia—Estramustine—prostate cancer	0.000824	0.00801	CcSEcCtD
Altretamine—Neurotoxicity—Docetaxel—prostate cancer	0.000811	0.00789	CcSEcCtD
Altretamine—Myelosuppression—Etoposide—prostate cancer	0.000807	0.00785	CcSEcCtD
Altretamine—Neoplasm—Bicalutamide—prostate cancer	0.000801	0.00779	CcSEcCtD
Altretamine—Neurotoxicity—Capecitabine—prostate cancer	0.000785	0.00764	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Epirubicin—prostate cancer	0.000742	0.00722	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Bicalutamide—prostate cancer	0.000739	0.00719	CcSEcCtD
Altretamine—Neoplasm malignant—Conjugated Estrogens—prostate cancer	0.000715	0.00695	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Doxorubicin—prostate cancer	0.000687	0.00668	CcSEcCtD
Altretamine—Neoplasm—Ethinyl Estradiol—prostate cancer	0.000677	0.00658	CcSEcCtD
Altretamine—Myelosuppression—Docetaxel—prostate cancer	0.000671	0.00652	CcSEcCtD
Altretamine—Neoplasm malignant—Estradiol—prostate cancer	0.000572	0.00556	CcSEcCtD
Altretamine—Neuropathy peripheral—Cabazitaxel—prostate cancer	0.000566	0.0055	CcSEcCtD
Altretamine—Neoplasm—Goserelin—prostate cancer	0.000557	0.00542	CcSEcCtD
Altretamine—Neoplasm—Conjugated Estrogens—prostate cancer	0.000552	0.00536	CcSEcCtD
Altretamine—Neurotoxicity—Epirubicin—prostate cancer	0.000547	0.00532	CcSEcCtD
Altretamine—Anaemia—Abiraterone—prostate cancer	0.000543	0.00528	CcSEcCtD
Altretamine—Leukopenia—Estramustine—prostate cancer	0.000541	0.00526	CcSEcCtD
Altretamine—Neurotoxicity—Doxorubicin—prostate cancer	0.000506	0.00492	CcSEcCtD
Altretamine—Anaemia—Nilutamide—prostate cancer	0.000496	0.00482	CcSEcCtD
Altretamine—Anaemia—Flutamide—prostate cancer	0.000493	0.0048	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Estradiol—prostate cancer	0.000488	0.00475	CcSEcCtD
Altretamine—Neuropathy peripheral—Bicalutamide—prostate cancer	0.000486	0.00472	CcSEcCtD
Altretamine—Thrombocytopenia—Estramustine—prostate cancer	0.000483	0.0047	CcSEcCtD
Altretamine—Leukopenia—Nilutamide—prostate cancer	0.00048	0.00467	CcSEcCtD
Altretamine—Leukopenia—Flutamide—prostate cancer	0.000478	0.00465	CcSEcCtD
Altretamine—Anorexia—Estramustine—prostate cancer	0.00047	0.00457	CcSEcCtD
Altretamine—Myelosuppression—Epirubicin—prostate cancer	0.000452	0.0044	CcSEcCtD
Altretamine—Anaemia—Degarelix—prostate cancer	0.000443	0.00431	CcSEcCtD
Altretamine—Neoplasm—Estradiol—prostate cancer	0.000442	0.00429	CcSEcCtD
Altretamine—Decreased appetite—Estramustine—prostate cancer	0.000429	0.00417	CcSEcCtD
Altretamine—Thrombocytopenia—Flutamide—prostate cancer	0.000427	0.00415	CcSEcCtD
Altretamine—Myelosuppression—Doxorubicin—prostate cancer	0.000419	0.00407	CcSEcCtD
Altretamine—Anorexia—Nilutamide—prostate cancer	0.000417	0.00406	CcSEcCtD
Altretamine—Anaemia—Cabazitaxel—prostate cancer	0.000417	0.00406	CcSEcCtD
Altretamine—Anorexia—Flutamide—prostate cancer	0.000415	0.00404	CcSEcCtD
Altretamine—Fatigue—Abiraterone—prostate cancer	0.000413	0.00402	CcSEcCtD
Altretamine—Neuropathy peripheral—Ethinyl Estradiol—prostate cancer	0.00041	0.00399	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Estradiol—prostate cancer	0.000408	0.00396	CcSEcCtD
Altretamine—Vertigo—Cabazitaxel—prostate cancer	0.000405	0.00394	CcSEcCtD
Altretamine—Leukopenia—Cabazitaxel—prostate cancer	0.000404	0.00393	CcSEcCtD
Altretamine—Decreased appetite—Nilutamide—prostate cancer	0.00038	0.0037	CcSEcCtD
Altretamine—Decreased appetite—Flutamide—prostate cancer	0.000379	0.00368	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Etoposide—prostate cancer	0.000378	0.00368	CcSEcCtD
Altretamine—Fatigue—Flutamide—prostate cancer	0.000376	0.00365	CcSEcCtD
Altretamine—Thrombocytopenia—Cabazitaxel—prostate cancer	0.000361	0.00351	CcSEcCtD
Altretamine—Anaemia—Bicalutamide—prostate cancer	0.000358	0.00348	CcSEcCtD
Altretamine—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.000355	0.00345	CcSEcCtD
Altretamine—Anorexia—Cabazitaxel—prostate cancer	0.000351	0.00341	CcSEcCtD
Altretamine—Asthenia—Abiraterone—prostate cancer	0.000344	0.00334	CcSEcCtD
Altretamine—Decreased appetite—Degarelix—prostate cancer	0.00034	0.0033	CcSEcCtD
Altretamine—Fatigue—Degarelix—prostate cancer	0.000337	0.00328	CcSEcCtD
Altretamine—Neuropathy peripheral—Conjugated Estrogens—prostate cancer	0.000335	0.00325	CcSEcCtD
Altretamine—Decreased appetite—Cabazitaxel—prostate cancer	0.00032	0.00311	CcSEcCtD
Altretamine—Fatigue—Cabazitaxel—prostate cancer	0.000318	0.00309	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Etoposide—prostate cancer	0.000316	0.00307	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Docetaxel—prostate cancer	0.000315	0.00306	CcSEcCtD
Altretamine—Asthenia—Nilutamide—prostate cancer	0.000314	0.00305	CcSEcCtD
Altretamine—Vomiting—Estramustine—prostate cancer	0.000314	0.00305	CcSEcCtD
Altretamine—Asthenia—Flutamide—prostate cancer	0.000313	0.00304	CcSEcCtD
Altretamine—Dizziness—Estrone—prostate cancer	0.000312	0.00303	CcSEcCtD
Altretamine—Thrombocytopenia—Bicalutamide—prostate cancer	0.000309	0.00301	CcSEcCtD
Altretamine—Vomiting—Abiraterone—prostate cancer	0.000305	0.00296	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Capecitabine—prostate cancer	0.000305	0.00296	CcSEcCtD
Altretamine—Anorexia—Bicalutamide—prostate cancer	0.000301	0.00293	CcSEcCtD
Altretamine—Vomiting—Estrone—prostate cancer	0.0003	0.00291	CcSEcCtD
Altretamine—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000295	0.00287	CcSEcCtD
Altretamine—Nausea—Estramustine—prostate cancer	0.000293	0.00285	CcSEcCtD
Altretamine—Dizziness—Nilutamide—prostate cancer	0.000289	0.00281	CcSEcCtD
Altretamine—Dizziness—Flutamide—prostate cancer	0.000288	0.0028	CcSEcCtD
Altretamine—Neoplasm—Docetaxel—prostate cancer	0.000284	0.00277	CcSEcCtD
Altretamine—Asthenia—Degarelix—prostate cancer	0.00028	0.00273	CcSEcCtD
Altretamine—Nausea—Estrone—prostate cancer	0.00028	0.00272	CcSEcCtD
Altretamine—Vomiting—Nilutamide—prostate cancer	0.000278	0.00271	CcSEcCtD
Altretamine—Vomiting—Flutamide—prostate cancer	0.000277	0.00269	CcSEcCtD
Altretamine—Neoplasm—Capecitabine—prostate cancer	0.000275	0.00268	CcSEcCtD
Altretamine—Decreased appetite—Bicalutamide—prostate cancer	0.000275	0.00267	CcSEcCtD
Altretamine—Fatigue—Bicalutamide—prostate cancer	0.000272	0.00265	CcSEcCtD
Altretamine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000272	0.00264	CcSEcCtD
Altretamine—Pancytopenia—Mitoxantrone—prostate cancer	0.000271	0.00264	CcSEcCtD
Altretamine—Neuropathy peripheral—Estradiol—prostate cancer	0.000268	0.0026	CcSEcCtD
Altretamine—Asthenia—Cabazitaxel—prostate cancer	0.000264	0.00257	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Docetaxel—prostate cancer	0.000263	0.00255	CcSEcCtD
Altretamine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000261	0.00254	CcSEcCtD
Altretamine—Nausea—Nilutamide—prostate cancer	0.00026	0.00253	CcSEcCtD
Altretamine—Nausea—Flutamide—prostate cancer	0.000259	0.00252	CcSEcCtD
Altretamine—Dizziness—Degarelix—prostate cancer	0.000259	0.00251	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Capecitabine—prostate cancer	0.000254	0.00247	CcSEcCtD
Altretamine—Anaemia—Goserelin—prostate cancer	0.000249	0.00242	CcSEcCtD
Altretamine—Vomiting—Degarelix—prostate cancer	0.000249	0.00242	CcSEcCtD
Altretamine—Neoplasm malignant—Epirubicin—prostate cancer	0.000248	0.00242	CcSEcCtD
Altretamine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000244	0.00238	CcSEcCtD
Altretamine—Dizziness—Cabazitaxel—prostate cancer	0.000244	0.00237	CcSEcCtD
Altretamine—Leukopenia—Goserelin—prostate cancer	0.000241	0.00234	CcSEcCtD
Altretamine—Vertigo—Conjugated Estrogens—prostate cancer	0.00024	0.00233	CcSEcCtD
Altretamine—Vomiting—Cabazitaxel—prostate cancer	0.000234	0.00228	CcSEcCtD
Altretamine—Convulsion—Goserelin—prostate cancer	0.000233	0.00227	CcSEcCtD
Altretamine—Nausea—Degarelix—prostate cancer	0.000232	0.00226	CcSEcCtD
Altretamine—Convulsion—Conjugated Estrogens—prostate cancer	0.000231	0.00225	CcSEcCtD
Altretamine—Fatigue—Ethinyl Estradiol—prostate cancer	0.00023	0.00224	CcSEcCtD
Altretamine—Neoplasm malignant—Doxorubicin—prostate cancer	0.00023	0.00224	CcSEcCtD
Altretamine—Asthenia—Bicalutamide—prostate cancer	0.000227	0.0022	CcSEcCtD
Altretamine—Pancytopenia—Etoposide—prostate cancer	0.000226	0.00219	CcSEcCtD
Altretamine—Nausea—Cabazitaxel—prostate cancer	0.000219	0.00213	CcSEcCtD
Altretamine—Thrombocytopenia—Goserelin—prostate cancer	0.000215	0.00209	CcSEcCtD
Altretamine—Ataxia—Docetaxel—prostate cancer	0.000215	0.00209	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Epirubicin—prostate cancer	0.000212	0.00206	CcSEcCtD
Altretamine—Anorexia—Goserelin—prostate cancer	0.000209	0.00204	CcSEcCtD
Altretamine—Dizziness—Bicalutamide—prostate cancer	0.000209	0.00203	CcSEcCtD
Altretamine—Ataxia—Capecitabine—prostate cancer	0.000208	0.00202	CcSEcCtD
Altretamine—Neuropathy peripheral—Etoposide—prostate cancer	0.000208	0.00202	CcSEcCtD
Altretamine—Anorexia—Conjugated Estrogens—prostate cancer	0.000208	0.00202	CcSEcCtD
Altretamine—Vomiting—Bicalutamide—prostate cancer	0.000201	0.00195	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Doxorubicin—prostate cancer	0.000196	0.00191	CcSEcCtD
Altretamine—Neoplasm—Epirubicin—prostate cancer	0.000192	0.00187	CcSEcCtD
Altretamine—Vertigo—Estradiol—prostate cancer	0.000192	0.00187	CcSEcCtD
Altretamine—Asthenia—Ethinyl Estradiol—prostate cancer	0.000192	0.00186	CcSEcCtD
Altretamine—Decreased appetite—Goserelin—prostate cancer	0.000191	0.00186	CcSEcCtD
Altretamine—Fatigue—Goserelin—prostate cancer	0.000189	0.00184	CcSEcCtD
Altretamine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000189	0.00184	CcSEcCtD
Altretamine—Fatigue—Conjugated Estrogens—prostate cancer	0.000188	0.00183	CcSEcCtD
Altretamine—Nausea—Bicalutamide—prostate cancer	0.000188	0.00182	CcSEcCtD
Altretamine—Pancytopenia—Docetaxel—prostate cancer	0.000187	0.00182	CcSEcCtD
Altretamine—Anaemia—Mitoxantrone—prostate cancer	0.000184	0.00179	CcSEcCtD
Altretamine—Pancytopenia—Capecitabine—prostate cancer	0.000181	0.00176	CcSEcCtD
Altretamine—Leukopenia—Mitoxantrone—prostate cancer	0.000178	0.00173	CcSEcCtD
Altretamine—Neoplasm—Doxorubicin—prostate cancer	0.000177	0.00173	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Epirubicin—prostate cancer	0.000177	0.00172	CcSEcCtD
Altretamine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000177	0.00172	CcSEcCtD
Altretamine—Neuropathy peripheral—Docetaxel—prostate cancer	0.000172	0.00168	CcSEcCtD
Altretamine—Convulsion—Mitoxantrone—prostate cancer	0.000172	0.00168	CcSEcCtD
Altretamine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00017	0.00165	CcSEcCtD
Altretamine—Neuropathy peripheral—Capecitabine—prostate cancer	0.000167	0.00162	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Doxorubicin—prostate cancer	0.000164	0.00159	CcSEcCtD
Altretamine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000159	0.00155	CcSEcCtD
Altretamine—Nausea—Ethinyl Estradiol—prostate cancer	0.000159	0.00154	CcSEcCtD
Altretamine—Asthenia—Goserelin—prostate cancer	0.000158	0.00153	CcSEcCtD
Altretamine—Asthenia—Conjugated Estrogens—prostate cancer	0.000156	0.00152	CcSEcCtD
Altretamine—Anorexia—Mitoxantrone—prostate cancer	0.000155	0.0015	CcSEcCtD
Altretamine—Anaemia—Etoposide—prostate cancer	0.000153	0.00149	CcSEcCtD
Altretamine—Decreased appetite—Estradiol—prostate cancer	0.000151	0.00147	CcSEcCtD
Altretamine—Fatigue—Estradiol—prostate cancer	0.00015	0.00146	CcSEcCtD
Altretamine—Neuropathy peripheral—Prednisone—prostate cancer	0.000149	0.00145	CcSEcCtD
Altretamine—Vertigo—Etoposide—prostate cancer	0.000149	0.00145	CcSEcCtD
Altretamine—Leukopenia—Etoposide—prostate cancer	0.000148	0.00144	CcSEcCtD
Altretamine—Dizziness—Goserelin—prostate cancer	0.000145	0.00141	CcSEcCtD
Altretamine—Ataxia—Epirubicin—prostate cancer	0.000145	0.00141	CcSEcCtD
Altretamine—Dizziness—Conjugated Estrogens—prostate cancer	0.000144	0.0014	CcSEcCtD
Altretamine—Convulsion—Etoposide—prostate cancer	0.000143	0.00139	CcSEcCtD
Altretamine—Decreased appetite—Mitoxantrone—prostate cancer	0.000141	0.00137	CcSEcCtD
Altretamine—Fatigue—Mitoxantrone—prostate cancer	0.00014	0.00136	CcSEcCtD
Altretamine—Vomiting—Goserelin—prostate cancer	0.00014	0.00136	CcSEcCtD
Altretamine—Vomiting—Conjugated Estrogens—prostate cancer	0.000138	0.00135	CcSEcCtD
Altretamine—Ataxia—Doxorubicin—prostate cancer	0.000134	0.0013	CcSEcCtD
Altretamine—Thrombocytopenia—Etoposide—prostate cancer	0.000132	0.00129	CcSEcCtD
Altretamine—Nausea—Goserelin—prostate cancer	0.000131	0.00127	CcSEcCtD
Altretamine—Nausea—Conjugated Estrogens—prostate cancer	0.000129	0.00126	CcSEcCtD
Altretamine—Anorexia—Etoposide—prostate cancer	0.000129	0.00125	CcSEcCtD
Altretamine—Anaemia—Docetaxel—prostate cancer	0.000127	0.00124	CcSEcCtD
Altretamine—Pancytopenia—Epirubicin—prostate cancer	0.000126	0.00123	CcSEcCtD
Altretamine—Asthenia—Estradiol—prostate cancer	0.000125	0.00122	CcSEcCtD
Altretamine—Leukopenia—Docetaxel—prostate cancer	0.000123	0.0012	CcSEcCtD
Altretamine—Anaemia—Capecitabine—prostate cancer	0.000123	0.0012	CcSEcCtD
Altretamine—Vertigo—Capecitabine—prostate cancer	0.00012	0.00116	CcSEcCtD
Altretamine—Leukopenia—Capecitabine—prostate cancer	0.000119	0.00116	CcSEcCtD
Altretamine—Convulsion—Docetaxel—prostate cancer	0.000119	0.00116	CcSEcCtD
Altretamine—Decreased appetite—Etoposide—prostate cancer	0.000117	0.00114	CcSEcCtD
Altretamine—Pancytopenia—Doxorubicin—prostate cancer	0.000117	0.00114	CcSEcCtD
Altretamine—Asthenia—Mitoxantrone—prostate cancer	0.000116	0.00113	CcSEcCtD
Altretamine—Fatigue—Etoposide—prostate cancer	0.000116	0.00113	CcSEcCtD
Altretamine—Neuropathy peripheral—Epirubicin—prostate cancer	0.000116	0.00113	CcSEcCtD
Altretamine—Dizziness—Estradiol—prostate cancer	0.000115	0.00112	CcSEcCtD
Altretamine—Vomiting—Estradiol—prostate cancer	0.000111	0.00108	CcSEcCtD
Altretamine—Thrombocytopenia—Docetaxel—prostate cancer	0.00011	0.00107	CcSEcCtD
Altretamine—Anaemia—Prednisone—prostate cancer	0.00011	0.00107	CcSEcCtD
Altretamine—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000108	0.00105	CcSEcCtD
Altretamine—Anorexia—Docetaxel—prostate cancer	0.000107	0.00104	CcSEcCtD
Altretamine—Vertigo—Prednisone—prostate cancer	0.000107	0.00104	CcSEcCtD
Altretamine—Thrombocytopenia—Capecitabine—prostate cancer	0.000106	0.00103	CcSEcCtD
Altretamine—Anorexia—Capecitabine—prostate cancer	0.000104	0.00101	CcSEcCtD
Altretamine—Nausea—Estradiol—prostate cancer	0.000103	0.00101	CcSEcCtD
Altretamine—Vomiting—Mitoxantrone—prostate cancer	0.000103	0.001	CcSEcCtD
Altretamine—Convulsion—Prednisone—prostate cancer	0.000103	0.000999	CcSEcCtD
Altretamine—Decreased appetite—Docetaxel—prostate cancer	9.76e-05	0.000949	CcSEcCtD
Altretamine—Asthenia—Etoposide—prostate cancer	9.69e-05	0.000942	CcSEcCtD
Altretamine—Fatigue—Docetaxel—prostate cancer	9.68e-05	0.000941	CcSEcCtD
Altretamine—Nausea—Mitoxantrone—prostate cancer	9.64e-05	0.000938	CcSEcCtD
Altretamine—Decreased appetite—Capecitabine—prostate cancer	9.44e-05	0.000918	CcSEcCtD
Altretamine—Fatigue—Capecitabine—prostate cancer	9.37e-05	0.000911	CcSEcCtD
Altretamine—Anorexia—Prednisone—prostate cancer	9.23e-05	0.000897	CcSEcCtD
Altretamine—Dizziness—Etoposide—prostate cancer	8.93e-05	0.000868	CcSEcCtD
Altretamine—Vomiting—Etoposide—prostate cancer	8.59e-05	0.000835	CcSEcCtD
Altretamine—Anaemia—Epirubicin—prostate cancer	8.57e-05	0.000834	CcSEcCtD
Altretamine—Decreased appetite—Prednisone—prostate cancer	8.41e-05	0.000818	CcSEcCtD
Altretamine—Fatigue—Prednisone—prostate cancer	8.34e-05	0.000811	CcSEcCtD
Altretamine—Vertigo—Epirubicin—prostate cancer	8.33e-05	0.00081	CcSEcCtD
Altretamine—Leukopenia—Epirubicin—prostate cancer	8.3e-05	0.000807	CcSEcCtD
Altretamine—Asthenia—Docetaxel—prostate cancer	8.05e-05	0.000783	CcSEcCtD
Altretamine—Convulsion—Epirubicin—prostate cancer	8.04e-05	0.000781	CcSEcCtD
Altretamine—Nausea—Etoposide—prostate cancer	8.02e-05	0.00078	CcSEcCtD
Altretamine—Anaemia—Doxorubicin—prostate cancer	7.93e-05	0.000771	CcSEcCtD
Altretamine—Asthenia—Capecitabine—prostate cancer	7.8e-05	0.000758	CcSEcCtD
Altretamine—Vertigo—Doxorubicin—prostate cancer	7.71e-05	0.00075	CcSEcCtD
Altretamine—Leukopenia—Doxorubicin—prostate cancer	7.68e-05	0.000747	CcSEcCtD
Altretamine—Convulsion—Doxorubicin—prostate cancer	7.44e-05	0.000723	CcSEcCtD
Altretamine—Dizziness—Docetaxel—prostate cancer	7.42e-05	0.000722	CcSEcCtD
Altretamine—Thrombocytopenia—Epirubicin—prostate cancer	7.41e-05	0.000721	CcSEcCtD
Altretamine—Anorexia—Epirubicin—prostate cancer	7.22e-05	0.000702	CcSEcCtD
Altretamine—Dizziness—Capecitabine—prostate cancer	7.18e-05	0.000699	CcSEcCtD
Altretamine—Vomiting—Docetaxel—prostate cancer	7.14e-05	0.000694	CcSEcCtD
Altretamine—Asthenia—Prednisone—prostate cancer	6.94e-05	0.000675	CcSEcCtD
Altretamine—Vomiting—Capecitabine—prostate cancer	6.91e-05	0.000672	CcSEcCtD
Altretamine—Thrombocytopenia—Doxorubicin—prostate cancer	6.86e-05	0.000667	CcSEcCtD
Altretamine—Anorexia—Doxorubicin—prostate cancer	6.68e-05	0.000649	CcSEcCtD
Altretamine—Nausea—Docetaxel—prostate cancer	6.67e-05	0.000648	CcSEcCtD
Altretamine—Decreased appetite—Epirubicin—prostate cancer	6.58e-05	0.00064	CcSEcCtD
Altretamine—Fatigue—Epirubicin—prostate cancer	6.53e-05	0.000635	CcSEcCtD
Altretamine—Nausea—Capecitabine—prostate cancer	6.45e-05	0.000628	CcSEcCtD
Altretamine—Dizziness—Prednisone—prostate cancer	6.4e-05	0.000622	CcSEcCtD
Altretamine—Vomiting—Prednisone—prostate cancer	6.15e-05	0.000598	CcSEcCtD
Altretamine—Decreased appetite—Doxorubicin—prostate cancer	6.09e-05	0.000592	CcSEcCtD
Altretamine—Fatigue—Doxorubicin—prostate cancer	6.04e-05	0.000587	CcSEcCtD
Altretamine—Nausea—Prednisone—prostate cancer	5.75e-05	0.000559	CcSEcCtD
Altretamine—Asthenia—Epirubicin—prostate cancer	5.43e-05	0.000528	CcSEcCtD
Altretamine—Asthenia—Doxorubicin—prostate cancer	5.02e-05	0.000489	CcSEcCtD
Altretamine—Dizziness—Epirubicin—prostate cancer	5.01e-05	0.000487	CcSEcCtD
Altretamine—Vomiting—Epirubicin—prostate cancer	4.81e-05	0.000468	CcSEcCtD
Altretamine—Dizziness—Doxorubicin—prostate cancer	4.63e-05	0.00045	CcSEcCtD
Altretamine—Nausea—Epirubicin—prostate cancer	4.5e-05	0.000437	CcSEcCtD
Altretamine—Vomiting—Doxorubicin—prostate cancer	4.45e-05	0.000433	CcSEcCtD
Altretamine—Nausea—Doxorubicin—prostate cancer	4.16e-05	0.000405	CcSEcCtD
